nach oben

International Ophthalmology

Erschienen in:

03.07.2020

SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models

verfasst von: Piergiorgio Neri, Massimo Lamperti, Francesco Pichi

Erschienen in: International Ophthalmology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Excerpt

Since its outbreak in early 2020, the novel coronavirus Severe Acute Respiratory Syndrome (SARS)-COV-2, formerly known as Covid-19, has affected more than 5 million people worldwide with a mortality rate of about 6.6%, making it roughly 6 times more lethal than influenza virus [1]. …

WHO (2020) Coronavirus disease 2019 (COVID-19) situation report—126. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200525-covid-19-sitrep-126.pdf?sfvrsn=887dbd66_2

Vetrugno L, Bove T, Orso D et al (2020) Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19. Echocardiography 37(4):625–627. https://doi.org/10.1111/echo.14664 CrossRefPubMed

Diotallevi F, Campanati A, Bianchelli T et al (2020) Skin involvement in SARS-CoV-2 infection: case series. J Med Virol. https://doi.org/10.1002/jmv.26012 CrossRefPubMedPubMedCentral

Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413:116832. https://doi.org/10.1016/j.jns.2020.116832 CrossRefPubMedPubMedCentral

Mao R, Qiu Y, He JS et al (2020) Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. https://doi.org/10.1016/S2468-1253(20)30126-6 CrossRefPubMedPubMedCentral

Marinho PM, Marcos AAA, Romano AC et al (2020) Retinal findings in patients with COVID-19. Lancet 395(10237):1610. https://doi.org/10.1016/S0140-6736(20)31014-X CrossRefPubMedPubMedCentral

Menter T, Haslbauer JD, Nienhold R et al (2020) Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology. https://doi.org/10.1111/his.14134 CrossRefPubMedPubMedCentral

Liu K, Chen Y, Lin R et al (2020) Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 80(6):e14–e18. https://doi.org/10.1016/j.jinf.2020.03.005 CrossRefPubMedPubMedCentral

Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033CrossRefPubMedPubMedCentral

10.

Schulert GS, Cron RQ (2020) The genetics of macrophage activation syndrome. Genes Immun. https://doi.org/10.1038/s41435-020-0098-4 CrossRefPubMed

11.

Shang L, Zhao J, Hu Y et al (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395(10225):683–684CrossRefPubMedPubMedCentral

12.

Stahl JP, Mailles A (2019) Herpes simplex virus encephalitis update. Curr Opin Infect Dis 32(3):239–243CrossRefPubMed

13.

Xu J, Tan DY, Fu YY et al (2015) Do corticosteroids have a role in treating Ebola virus disease? Sci China Life Sci 58(1):111–113CrossRefPubMed

14.

Pilotto A, Odolini S, Stefano Masciocchi S et al (2020) Steroid-responsive encephalitis in Covid-19 disease. Ann Neurol. https://doi.org/10.1002/ana.25783 CrossRefPubMedPubMedCentral

15.

Ledford H (2020) Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. https://doi.org/10.1038/d41586-020-01824-5 CrossRefPubMed

16.

Neri P, Pichi F (2020) COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol 40(5):1057–1060. https://doi.org/10.1007/s10792-020-01389-2 CrossRefPubMedPubMedCentral

17.

Scott LJ (2017) Tocilizumab: a review in rheumatoid arthritis [published correction appears in Drugs. 2017 Dec 19]. Drugs 77(17):1865–1879. https://doi.org/10.1007/s40265-017-0829-7 CrossRefPubMedPubMedCentral

18.

Wang Z, Wu Z, Liu Y et al (2017) New development in CAR-T cell therapy. J Hematol Oncol 10(1):53. https://doi.org/10.1186/s13045-017-0423-1 CrossRefPubMedPubMedCentral

19.

Zhang C, Wu Z, Li JW et al (2020) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 29:105954. https://doi.org/10.1016/j.ijantimicag.2020.105954 CrossRef

20.

Hooper LC, Chin MS, Detrick B et al (2005) Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling. J Neuroimmunol 166(1–2):65–74. https://doi.org/10.1016/j.jneuroim.2005.05.018 CrossRefPubMedPubMedCentral

21.

Tay MZ, Poh CM, Rénia L et al (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. https://doi.org/10.1038/s41577-020-0311-8 CrossRefPubMedPubMedCentral

22.

Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60. https://doi.org/10.1056/NEJMc2009787 CrossRefPubMed

23.

Toniati P, Piva S, Cattalini M et al (2020) Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia Italy. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2020.102568 CrossRefPubMedPubMedCentral

24.

Xu X, Han M, Li T et al (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA 117(20):10970–10975. https://doi.org/10.1073/pnas.2005615117 CrossRefPubMedPubMedCentral

25.

Radbel J, Narayanan N, Bhatt PJ (2020) Use of Tocilizumab for COVID-19-induced cytokine release syndrome: a cautionary case report. Chest S0012–3692(20):30764–9. https://doi.org/10.1016/j.chest.2020.04.024 CrossRef

26.

Teoh SC, Sharma S, Hogan A et al (2007) Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Br J Ophthalmol 91(2):263–264. https://doi.org/10.1136/bjo.2006.0101477 CrossRefPubMedPubMedCentral

27.

Dimopoulos G, de Mast Q, Markou N et al (2020) Favorable anakinra responses in severe covid-19 patients with secondary hemophagocytic lymphohistiocytosis. Cell Host Microbe. https://doi.org/10.1016/j.chom.2020.05.007 CrossRefPubMedPubMedCentral

28.

A trial of validation and restoration of immune dysfunction in severe infections and sepsis (PROVIDE). https://clinicaltrials.gov/ct2/show/NCT03332225

29.

Liang L, Tan X, Zhou Q et al (2013) IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease. Invest Ophthalmol Vis Sci 54(1):402–414. https://doi.org/10.1167/iovs.12-11047 CrossRefPubMed

30.

Zhao C, Zhao W (2020) NLRP3 inflammasome-a key player in antiviral responses. Front Immunol 11:211. https://doi.org/10.3389/fimmu.2020.00211 CrossRefPubMedPubMedCentral

31.

Nieto-Torres JL, Verdia-Baguena C, Jimenez-Guardeno JM et al (2015) Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 485:330–339. https://doi.org/10.1016/j.virol.2015.08.010 CrossRefPubMed

32.

Niu JL, Wu SX, Chen MK et al (2019) Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1 beta mediated neutrophil recruitment. Cytokine 120:115–124. https://doi.org/10.1016/j.cyto.2019.04.019 CrossRefPubMed

33.

Kernan KF, Ghaloul-Gonzalez L, Shakoory B et al (2019) Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation. Genes Immun 20(6):520–526. https://doi.org/10.1038/s41435-018-0030-3 CrossRefPubMed

34.

Monteagudo LA, Boothby A, Gertner E (2020) Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome. ACR Open Rheumatol 2(5):276–282. https://doi.org/10.1002/acr2.11135 CrossRefPubMedPubMedCentral

35.

Norelli M, Camisa B, Barbiera G et al (2018) Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat Med 24(6):739–748. https://doi.org/10.1038/s41591-018-0036-4 CrossRefPubMed

36.

Verdoni L, Mazza A, Gervasoni A et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. https://doi.org/10.1016/S0140-6736(20)31103-X CrossRefPubMedPubMedCentral

37.

Anzai F, Watanabe S, Kimura H et al (2020) Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease. J Mol Cell Cardiol 138:185–196. https://doi.org/10.1016/j.yjmcc.2019.11.158 CrossRefPubMed

Titel: SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models
verfasst von: Piergiorgio Neri
Massimo Lamperti
Francesco Pichi
Publikationsdatum: 03.07.2020
Verlag: Springer Netherlands
Erschienen in: International Ophthalmology / Ausgabe 8/2020
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-020-01495-1

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models

Excerpt

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2020

Optic disc drusen: a systematic review

Anterior chamber angle width, central vault and intraocular pressure changes after 12 months of Visian collamer lens implantation

Efficacy of navigated focal laser photocoagulation in diabetic macular edema planned with en face optical coherence tomography versus fluorescein angiography

Chronically retained feathery chestnut-burr spine-related corneal injury: clinical features and outcome

The effect of topical tropicamide and phenylephrine on macular and peripapillary microvasculature: an optical coherence tomography angiography study

Swept-source optical coherence tomography angiography alleviates shadowing artifacts caused by subretinal fluid

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde